Actively Recruiting
Autologous Adipose Cell Therapy for Improving Skin and Hair A Phase 1 and 2 Study Evaluating Safety and Effectiveness in Adults
Led by CERM INC. · Updated on 2025-05-31
40
Participants Needed
2
Research Sites
13 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating Autologous Adipose Cell Therapy to improve skin rejuvenation and hair restoration. This therapy aims to overcome the limitations of traditional fat grafting and dermal fillers by isolating early-stage fat cells for better distribution and longer-lasting effects. The study focuses on assessing the safety, feasibility, and effectiveness of this therapy for conditions like wrinkles, fine lines, skin elasticity loss, pigmentation, hair thinning, and hair loss. Participants will receive the Autologous Adipose Cells therapy treatment, which involves processing fat cells from their own body to enhance skin and hair appearance. The therapy is monitored by the primary investigator for up to 25 weeks to evaluate outcomes. This study includes only one treatment group receiving this biological intervention. During the study, participants will undergo various assessments including imaging, satisfaction surveys, and evaluation reports from the first visit before treatment through the last follow-up visit between weeks 16 and 25. The plastic surgeon will monitor treatment effects and safety over a six-month period. The total involvement spans from initial treatment to multiple follow-ups to track skin and hair improvements and participant satisfaction.
CONDITIONS
Brief Title
Autologous Adipose Cells Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Outpatients interested in skin rejuvenation or experiencing skin conditions such as wrinkles, fine lines, loss of skin elasticity, pigmentation, or scarring
- Outpatients experiencing hair loss or hair thinning
- Signed and dated informed consent form provided
- Willingness to comply with all study procedures and availability for the study
- Female or male aged between 21 to 80 years
- Medical clearance by family doctor
You will not qualify if you...
- Pregnancy or lactation
- Known allergic reaction to components of cell culture media
- Chronic diseases such as cardiovascular disease, diabetes, chronic kidney disease, or seizures
- Chronic infections like skin fungi infection or psoriasis
- Chronic wound healing problems
- Currently taking hormone therapy
- History of cancers or active cancers
- Viral infections such as HIV, hepatitis B, influenza, or coronaviruses
Research Team
A
Ankeet Dixit
W
Wing Nam Fung
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here